Herbalife (NYSE:HLF) Downgraded by StockNews.com

StockNews.com lowered shares of Herbalife (NYSE:HLF) from a buy rating to a hold rating in a research note issued to investors on Tuesday.

Other research analysts have also issued research reports about the stock. B. Riley upped their price target on shares of Herbalife from $16.00 to $17.00 and gave the company a “buy” rating in a research note on Thursday, August 1st. DA Davidson upped their target price on Herbalife from $9.50 to $13.00 and gave the company a “neutral” rating in a research report on Thursday, August 1st. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $12.40.

Herbalife Trading Down 0.9 %

Shares of HLF stock opened at $6.92 on Tuesday. Herbalife has a 12-month low of $6.59 and a 12-month high of $15.66. The business’s fifty day simple moving average is $7.46 and its 200-day simple moving average is $9.34. The company has a market cap of $691.28 million, a PE ratio of 5.05, a PEG ratio of 0.27 and a beta of 1.19.

Herbalife (NYSE:HLF) last announced its earnings results on Wednesday, July 31st. The company reported $0.54 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.43 by $0.11. The company had revenue of $1.28 billion for the quarter, compared to analyst estimates of $1.33 billion. Herbalife had a negative return on equity of 18.69% and a net margin of 1.63%. The firm’s quarterly revenue was down 2.5% compared to the same quarter last year. During the same period in the prior year, the company posted $0.74 EPS. On average, equities analysts forecast that Herbalife will post 1.34 earnings per share for the current year.

Insider Transactions at Herbalife

In other Herbalife news, Director Juan Miguel Mendoza bought 10,000 shares of the firm’s stock in a transaction that occurred on Monday, September 9th. The stock was bought at an average cost of $7.11 per share, for a total transaction of $71,100.00. Following the completion of the transaction, the director now directly owns 120,000 shares of the company’s stock, valued at approximately $853,200. This trade represents a 0.00 % increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 0.94% of the company’s stock.

Hedge Funds Weigh In On Herbalife

Several institutional investors and hedge funds have recently modified their holdings of HLF. GAMMA Investing LLC grew its holdings in Herbalife by 465.3% during the second quarter. GAMMA Investing LLC now owns 3,533 shares of the company’s stock worth $37,000 after acquiring an additional 2,908 shares during the period. nVerses Capital LLC increased its holdings in shares of Herbalife by 240.0% during the 2nd quarter. nVerses Capital LLC now owns 5,100 shares of the company’s stock valued at $53,000 after purchasing an additional 3,600 shares in the last quarter. Public Employees Retirement System of Ohio lifted its stake in shares of Herbalife by 22.9% in the 1st quarter. Public Employees Retirement System of Ohio now owns 5,558 shares of the company’s stock valued at $56,000 after purchasing an additional 1,035 shares during the period. Carolina Wealth Advisors LLC purchased a new stake in Herbalife during the third quarter worth $78,000. Finally, Van ECK Associates Corp grew its position in Herbalife by 10.3% during the second quarter. Van ECK Associates Corp now owns 8,684 shares of the company’s stock valued at $90,000 after buying an additional 808 shares during the period.

About Herbalife

Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.